References
- Yoo EG. Sitosterolemia: a review and update of pathophysiology, clinical spectrum, diagnosis, and management. Ann Pediatr Endocrinol Metab. 2016;21(1):7–14. doi:https://doi.org/10.6065/apem.2016.21.1.7. PMID: 27104173.
- Merkens LS, Myrie SB, Steiner RD, Mymin D. Sitosterolemia. In: Adam MP, Ardinger HH, Pagon RA, and Wallace SE, eds. GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 2013 Apr 4; 1993–2019. Updated 2018 May 17. https://www.ncbi.nlm.nih.gov/books/NBK131810/.
- Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest. 1974;53:1033–1043. doi:https://doi.org/10.1172/JCI107640. PMID:4360855.
- Tada H, Nohara A, Inazu A, Sakuma N, Mabuchi H, Kawashiri MA. Sitosterolemia, hypercholesterolemia, and coronary artery disease. J Atheroscler Thromb. 2018;25(9):783–789. doi:https://doi.org/10.5551/jat.RV17024. PMID: 30033951.
- Ajagbe BO, Othman RA. Myrie SB plant sterols, stanols, and Sitosterolemia. J AOAC Int. 2015;98(3):716–723. doi:https://doi.org/10.5740/jaoacint.SGEAjagbe. PMID: 25941971.
- Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181–188. doi:https://doi.org/10.5507/bp.2014.016. PMID: 24781043.
- Koopal C, Visseren FL, Marais AD, Westerink J, Spiering W. Tendon xanthomas: not always familial hypercholesterolemia. J Clin Lipidol. 2016;10(5):1262–1265. doi:https://doi.org/10.1016/j.jacl.2016.05.005. PMID: 27678445.
- Othman RA, Myrie SB, Mymin D, Roullet JB, Steiner RD, Jones PJH. Effect of ezetimibe on low- and high-density lipoprotein subclasses in sitosterolemia. Atherosclerosis. 2017;260:27–33. doi:https://doi.org/10.1016/j.atherosclerosis.2017.03.015. PMID: 28340366.